@article{ATM14677,
author = {Masahiko Asami},
title = {Favorable outcomes for female patients undergoing transcatheter aortic valve replacement?},
journal = {Annals of Translational Medicine},
volume = {5},
number = {16},
year = {2017},
keywords = {},
abstract = {Transcatheter aortic valve replacement (TAVR) is an established treatment for high surgical risk or inoperable patients with severe aortic stenosis (AS) (1-3). Interestingly, unlike percutaneous coronary intervention (PCI), approximately 50% of patients who undergo TAVR are female, despite the fact that female patients have fewer comorbidities than male patients (4-6). Furthermore, female patients have been found to have favorable outcomes as compared to male patients (5-10). However, to date, it remains unclear why male patients have a higher incidence of mortality after TAVR. Understanding this might help determine the effect of sex differences in patients with severe AS undergoing TAVR and should therefore be evaluated.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/14677}
}